ACM
PROF

Altium Capital Management’s Profound Medical PROF Stock Holding History

Altium Capital Management’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-360,589
Closed -$2.1M – 13
2025
Q1 		$2.1M Sell
360,589
-124,411
-26% -$859K 5.06% 7
2024
Q4 		$3.64M Buy
+485,000
New +$3.72M 1.03% 34
2022
Q2 		– Sell
-124,945
Closed -$1.13M – 136
2022
Q1 		$1.13M Sell
124,945
-175,055
-58% -$1.69M 0.38% 72
2021
Q4 		$3.37M Buy
300,000
+65,000
+28% +$812K 0.93% 43
2021
Q3 		$3.44M Buy
235,000
+24,720
+12% +$377K 0.9% 47
2021
Q2 		$3.44M Buy
210,280
+83,853
+66% +$1.56M 0.8% 51
2021
Q1 		$2.55M Buy
+126,427
New +$3.03M 0.71% 60

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Altium Capital Management's PROF Position: Q2 2025 in Review

Altium Capital Management sold out of Profound Medical (PROF) in Q2 2025, closing a stake of 360,589 shares — an estimated $2.1M sold.

Altium Capital Management first reported a position in PROF in Q1 2021 and held it in 7 quarters. The position peaked at $3.64M in Q4 2024. 44 funds tracked by Wall St. Rank hold PROF as of Q2 2025.

  • Altium Capital Management reported no remaining Profound Medical position as of Q2 2025 after selling out during the quarter.
  • Altium Capital Management sold 360,589 Profound Medical shares in Q2 2025, an estimated $2.1M.
  • Altium Capital Management first reported a position in Profound Medical in Q1 2021 and held it in 7 quarters.
  • Altium Capital Management's Profound Medical position peaked at $3.64M in Q4 2024.
  • 44 funds tracked by Wall St. Rank held Profound Medical as of Q2 2025.

Based on Altium Capital Management's 13F filing for Q2 2025.